Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Zuyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Viral Load, Papillomavirus Infections, Persistent Infection, Polymorphism, Genetic. Die Arbeit nennt 50 Literaturangaben. Gefördert von: This study was supported by grants from the National Natural Science Foundation of China (No.82302527), Guizhou Province "Thousand Talents" Plan (No. xmrc12024….
Abstract (Originalsprache)
Human papillomavirus type 58 (HPV58) poses a substantial burden in Asia; however, the interplay between its genetic variations, viral load, and clinical outcomes remains incompletely characterized. Therefore, we investigated HPV58 detection rates and E6 / E7 allele frequency trends, and analyzed the positive selection, viral load, pathogenicity, and persistent infection capacity associated with specific genotypes/mutations using 239 743 exfoliated cervical cell samples. Our results show a gradual increase in HPV58 detection rates over time. Allele replacement occurs slowly, with significant changes manifesting after long‐term accumulation. The E6 A388C(K93N) + E7 prototype enhanced short‐term persistent infection capacity without increasing high‐grade lesion pathogenicity, and its frequency increased. Conversely, E7 C632T (T20I) and G760A (G63S) mutations enhanced high‐grade lesion pathogenicity, whereas G761A (G63D) reduced pathogenicity. HPV58 improves adaptive ability by increasing the persistent infection capacity without increasing the risk of high‐grade lesions. High viral load was positively correlated with both pathogenicity and persistent infection capacity, suggesting its potential as a risk factor for predicting disease progression in HPV58 screening. No correlation was observed between HPV58 viral load and specific gene mutations/genotypes, indicating that alternative mechanisms likely drive allele replacement. This study provides insights to optimize HPV58 screening strategies and deepen understanding of its evolutionary dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- School of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
- Department of Reproductive Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Laboratory of Family Planning Service Center, Tongnan Maternal and Child Health Care Hospital, Chongqing, China.
- Department of Medical Laboratory, Qianxi People's Hospital, Qianxi, China.
- Department of Information, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Zuyi Chen, Qiongyao Li
Förderung
- This study was supported by grants from the National Natural Science Foundation of China (No.82302527), Guizhou Province "Thousand Talents" Plan (No. xmrc12024…
Zitieren
APA
Chen, Z., Cheng, Q., Mu, X., Liu, Y., Zhang, M., Tian, D., Huang, Y., Bai, X., Yang, Y., & Li, Q. (2025). Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58. Journal of Medical Virology. https://doi.org/10.1002/jmv.70502
Vancouver
Chen Z, Cheng Q, Mu X, Liu Y, Zhang M, Tian D, et al. Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58. Journal of Medical Virology. 2025. doi:10.1002/jmv.70502
BibTeX
@article{Chen2025,
author = {Chen, Zuyi and Cheng, Qichen and Mu, Xuejiao and Liu, Youbin and Zhang, Mingjing and Tian, Di and Huang, Yanlan and Bai, Xia and Yang, Yan and Li, Qiongyao},
title = {Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70502}
}
EUVIMED